P

Purushottam

Active Director Director DIN 10090686
DIN 10090686 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Purushottam

Data last updated:

Purushottam is a Director at Vernear Chemicals & Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Vernear Chemicals & Pharmaceuticals Private Limited reported revenue of ₹6.55 Cr (FY 2025).

DIN 10090686
Primary Designation Director
Industry Pharma
First Appointment 27 Mar 2023
Oldest Company Age 3 yrs
Largest company Vernear Chemicals & Pharmaceuticals Private Limited · ₹6.55 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 20232023₹6.55 Cr (FY 2025)Active

Board colleagues of Purushottam

Directorship timeline

Open interactive timeline →
Vernear Chemicals & Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Purushottam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purushottam

Purushottam currently holds 1 directorship: Vernear Chemicals & Pharmaceuticals Private Limited (Director, since 27 Mar 2023, revenue ₹6.55 Cr (FY 2025)).

Purushottam was first appointed on 27 Mar 2023 as Director at Vernear Chemicals & Pharmaceuticals Private Limited.

The current boards of Purushottam's companies include Nitesh Kumar (Vernear Chemicals & Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available